Advertisement
News
Advertisement

Semprus BioSciences' Lucchino joins AdvaMed board

Tue, 03/08/2011 - 12:35pm
Mass High Tech: The Journal of New England Technology

David L. Lucchino, CEO of Cambridge-based Semprus BioSciences, has been elected to the board of directors of the trade association Advanced Medical Technology Association (AdvaMed).

AdvaMed represents about 400 medical device and diagnostics manufacturers on legal, regulatory and economic issues. Based in Washington D.C., the association says that it promotes policies that foster high ethical standards, rapid product approvals, appropriate reimbursement and international market access. 

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading